Spintronics

Spintronics and the Future of Drug Design

David Alvaro, Ph.D.

Pharma's Almanac

Psychedelics

Unlocking the Potential of Psychedelics for Postpartum Depression

Greg Mayes, J.D.

Reunion Neuroscience

Drug Approvals

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Pharma's Almanac

Magnetogenetics

Magnetogenetics and the Future of Remote Biological Control

David Alvaro, Ph.D.

Pharma's Almanac

Advocacy

From Patients to Partners: The Rising Power of Advocacy in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

Biomarkers

The Biomarker Revolution in Medicine and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

HTS

The High-Throughput Screening Transformation in Modern Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

Accelerated Approval

30 Years of Accelerated Approvals: Fast-Tracking Innovation in Drug Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Structural Biology

The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation

David Alvaro, Ph.D.

Pharma's Almanac

Real-World Evidence

Overcoming Challenges and Unlocking the Potential of Real-World Evidence

David Alvaro, Ph.D.

Pharma's Almanac

Cannabinoids

Unlocking New Frontiers with Cannabinoid and Psychedelic Therapies

David Alvaro, Ph.D.

Pharma's Almanac

Biosimilars

Biosimilars Through the Years: Transforming Access and Cost in Biologics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Small Biotechs

Five Small Biotechs to Watch: March 2025

David Alvaro, Ph.D.

Pharma's Almanac

AI

Is AI truly transforming drug development, or are we still navigating through the hype?

Pharma's Almanac

Radioconjugates

Rising Interest in Radioconjugate Therapies

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Biotechs

Five Small Biotechs to Watch: February 2025

David Alvaro, Ph.D.

Pharma's Almanac

Bbiotherapeutics

Protein Science and the Future of Biotherapeutics

Mathias Uhlén, Ph.D.

NorthX Biologics

Autoimmune Diseases

Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities

Chia Chia Sun; Gardiner Smith

Fab Biopharma

LBPs

Exploring the Microbiome with Servatus

Servatus